GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fermenta Biotech Ltd (BOM:506414) » Definitions » Days Sales Outstanding

Fermenta Biotech (BOM:506414) Days Sales Outstanding : 44.17 (As of Dec. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Fermenta Biotech Days Sales Outstanding?

Fermenta Biotech's average Accounts Receivable for the three months ended in Dec. 2024 was ₹757 Mil. Fermenta Biotech's Revenue for the three months ended in Dec. 2024 was ₹1,565 Mil. Hence, Fermenta Biotech's Days Sales Outstanding for the three months ended in Dec. 2024 was 44.17.

The historical rank and industry rank for Fermenta Biotech's Days Sales Outstanding or its related term are showing as below:

BOM:506414' s Days Sales Outstanding Range Over the Past 10 Years
Min: 55.57   Med: 69.78   Max: 97.94
Current: 55.57

During the past 13 years, Fermenta Biotech's highest Days Sales Outstanding was 97.94. The lowest was 55.57. And the median was 69.78.

BOM:506414's Days Sales Outstanding is ranked better than
68.16% of 958 companies
in the Drug Manufacturers industry
Industry Median: 72.085 vs BOM:506414: 55.57

Fermenta Biotech's Days Sales Outstanding declined from Dec. 2023 (44.66) to Dec. 2024 (44.17).


Fermenta Biotech Days Sales Outstanding Historical Data

The historical data trend for Fermenta Biotech's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fermenta Biotech Days Sales Outstanding Chart

Fermenta Biotech Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 84.40 67.72 71.15 67.37 61.01

Fermenta Biotech Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 44.66 66.97 81.55 72.72 44.17

Competitive Comparison of Fermenta Biotech's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Fermenta Biotech's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fermenta Biotech's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Fermenta Biotech's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Fermenta Biotech's Days Sales Outstanding falls into.


;
;

Fermenta Biotech Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Fermenta Biotech's Days Sales Outstanding for the fiscal year that ended in Mar. 2024 is calculated as

Days Sales Outstanding (A: Mar. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Mar. 2023 ) + Accounts Receivable (A: Mar. 2024 )) / count ) / Revenue (A: Mar. 2024 )*Days in Period
=( (416.494 + 698.251) / 2 ) / 3334.625*365
=557.3725 / 3334.625*365
=61.01

Fermenta Biotech's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

Days Sales Outstanding (Q: Dec. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Sep. 2024 ) + Accounts Receivable (A: Dec. 2024 )) / count ) / Revenue (A: Dec. 2024 )*Days in Period
=( (757.342 + 0) / 1 ) / 1564.696*365 / 4
=757.342 / 1564.696*365 / 4
=44.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fermenta Biotech  (BOM:506414) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Fermenta Biotech Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Fermenta Biotech's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Fermenta Biotech Business Description

Traded in Other Exchanges
N/A
Address
Ghodbunder Road, A -1501, Thane One, DIL Complex, Majiwada, Thane (West), Thane, MH, IND, 400610
Fermenta Biotech Ltd is engaged in the business of manufacturing and marketing chemicals, bulk drugs, enzymes, pharmaceutical formulations, and environmental solution products and renting and selling properties. It is a manufacturer and supplier of Vitamin D and also supplies Penicillin G Amidase, CAL B Lipase, Polymer Supports, and enzyme technologies. The company operates in two segments that are Property and Bulk Drugs/Chemicals. The majority of the revenue comes from the Bulk Drug/Chemicals segment. Geographically, it caters to both domestic and international markets and generates maximum revenue from the Indian market.

Fermenta Biotech Headlines

No Headlines